Overview


According to FutureWise analysis the market for medical imaging in 2023 is US$ 33.92 billion, and is expected to reach US$ 50.19 billion by 2031 at a CAGR of 5.02%.

Medical imaging refers to the use of numerous technologies to visualize internal structures and functions of the body for diagnostic, monitoring, and therapeutic purposes. Medical imaging plays a critical role in modern medicine, allowing healthcare professionals to visualize the internal structures of the body without the need for invasive procedures. This helps in the diagnosis and treatment of various medical conditions, including cancer, cardiovascular disease, neurological disorders, and more. There are various types of medical imaging technologies, including X-rays, CT scans, MRI scans, ultrasound, and nuclear medicine imaging. Each of these technologies uses different principles to generate images of the body, and each has its own strengths and limitations.

X-rays employ electromagnetic radiation to produce images of the body and are commonly used for imaging bones and detecting fractures. CT scans use X-rays to generate multiple images of the body, which are subsequently reconstructed into a 3D image. CT scans are commonly used to detect tumors and other abnormalities. MRI creates comprehensive pictures of the body's soft tissues by using a strong magnetic field and radio waves, making it particularly useful for imaging the brain, spine, and joints. Ultrasound creates pictures of the body's interior structures by using high-frequency sound waves and is commonly used for imaging the fetus during pregnancy and for detecting abnormalities in the heart. Nuclear medicine imaging involves the injection of a small quantity of radioactive compound into the body, which is then recognized by a specific camera to capture images of the internal framework of the body.

FutureWise Market Research has published a report that provides an insightful analysis of Medical Imaging Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Medical Imaging Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Bruker
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions
  • TriFoil Imaging
  • PerkinElmer Inc.
  • Fujifilm VisualSonics Inc.
  • Cubresa Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The medical imaging market is constantly evolving and is driven by several factors, including advances in technology, the growing prevalence of chronic diseases, and increasing demand for minimally invasive procedures. Medical imaging refers to a range of technologies used to visualize internal structures and functions of the body for the purposes of diagnosis, monitoring, and treatment of various medical conditions. One of the major drivers of the medical imaging market is the growing prevalence of chronic diseases such as cancer, cardiovascular disease, and neurological disorders. Imaging techniques such as MRI, CT, and PET scans are widely used for the diagnosis and monitoring of these conditions. Another factor driving the growth of the medical imaging market is the growing need for procedures that are minimally invasive. Image-guided interventions have become more common, allowing for less invasive surgeries and procedures and reducing patient recovery time and risk of complications. Advancements in technology have also had a significant impact on the medical imaging market. The development of new imaging modalities, such as 3D and 4D imaging, and the increasing use of artificial intelligence (AI) in medical imaging analysis are expected to continue driving the market growth.

The medical imaging market is also affected by factors such as healthcare reform, reimbursement policies, and increasing pressure to reduce healthcare costs. Reimbursement policies have a significant impact on the adoption and utilization of medical imaging technologies, and changes in healthcare policies can affect market growth.

By Product

  • X-ray
    • By Modality
      • Radiography
      • Fluoroscopy
      • Computed Radiography
    • By Mobility
      • Stationary
      • Mobile
    • By product
      • Digital
      • Analog
    • By Application
      • General radiology
      • Dental
      • Breasts
      • Cardiology
      • Others
  • Ultrasound
    • By Product
      • 2D
      • 3D/4D
      • Doppler Ultrasound Devices
    • By Portability
      • Handheld
      • Cart/Trolley Based
    • By Application
      • Ob/Gyn
      • Cardiovascular
      • Musculoskeletal
      • Others
  • Computed Tomography
    • By Technology
      • High-end slice
      • Mid-end slice
      • Low-end slice
      • Cone beam
    • By Application
      • Oncology
      • Neurology
      • Cardiology
      • Vascular
      • Musculoskeletal
      • Others
  • Magnetic Resonance Imaging
    • By Architecture
      • Closed System
      • Open System
    • By Field Strength
      • Low Field Strength
      • Mid Field Strength
      • High Field Strength
    • By Application
      • Brain and neurological
      • Spine and musculoskeletal
      • Vascular
      • Abdomen
      • Cardiac
      • Breast
      • Other
  • Nuclear Imaging
    • By Product
      • SPECT
      • Hybrid SPECT
      • Standalone SPECT
      • Hybrid PET
      • Planar Scintigraphy
    • By Application
      • Oncology
      • Cardiology
      • Neurology
      • General Imaging

By End Use

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Imaging Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America is currently the biggest market for medical imaging, and the United States is the largest market within North America. This is due to several factors, including a well-established healthcare infrastructure, high healthcare expenditure, and a growing demand for advanced diagnostic and therapeutic technologies. The area is home to numerous significant market participants in the medical imaging sector, who have made significant investments in R&D, resulting in the creation of cutting-edge technology. Furthermore, favorable reimbursement policies in the United States have also influenced the expansion of the medical imaging market in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Medical Imaging Market By Product, By End Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Medical Imaging Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Medical Imaging Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Medical Imaging Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Medical Imaging Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. X-ray
         1.1. By Modality
          1.1.1. Radiography
          1.1.2. Fluoroscopy
          1.1.3. Computed Radiography
         1.2. By Mobility
          1.2.1. Stationary
          1.2.2. Mobile
         1.3. By product
          1.3.1. Digital
          1.3.2. Analog
         1.4. By Application
          1.4.1. General radiology
          1.4.2. Dental
          1.4.3. Breasts
          1.4.4. Cardiology
          1.4.5. Others
        2. Ultrasound
         2.1. By Product
          2.1.1. 2D
          2.1.2. 3D/4D
          2.1.3. Doppler Ultrasound Devices
         2.2. By Portability
          2.2.1. Handheld
          2.2.2. Cart/Trolley Based
         2.3. By Application
          2.3.1. Ob/Gyn
          2.3.2. Cardiovascular
          2.3.3. Musculoskeletal
          2.3.4. Others
        3. Computed Tomography
         3.1. By Technology
          3.1.1. High-end slice
          3.1.2. Mid-end slice
          3.1.3. Low-end slice
          3.1.4. Cone beam
         3.2. By Application
          3.2.1. Oncology
          3.2.2. Neurology
          3.2.3. Cardiology
          3.2.4. Vascular
          3.2.5. Musculoskeletal
          3.2.6. Others
        4. Magnetic Resonance Imaging
         4.1. By Architecture
          4.1.1. Closed System
          4.1.2. Open System
         4.2. By Field Strength
          4.2.1. Low Field Strength
          4.2.2. Mid Field Strength
          4.2.3. High Field Strength
         4.3. By Application
          4.3.1. Brain and neurological
          4.3.2. Spine and musculoskeletal
          4.3.3. Vascular
          4.3.4. Abdomen
          4.3.5. Cardiac
          4.3.6. Breast
          4.3.7. Other
        5. Nuclear Imaging
         5.1. By Product
          5.1.1. SPECT
           5.1.1.1. Hybrid SPECT
           5.1.1.2. Standalone SPECT
          5.1.2. Hybrid PET
          5.1.3. Planar Scintigraphy
         5.2. By Application
          5.2.1. Oncology
          5.2.2. Cardiology
          5.2.3. Neurology
          5.2.4. General Imaging

  • 8.   Medical Imaging Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Imaging Centers
        3. Ambulatory Imaging Centers
        4. Others

  • 9.   North America Medical Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Medical Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Medical Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Medical Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GE Healthcare
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Koninklijke Philips N.V.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Siemens Healthineers
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Canon Medical Systems Corporation.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bruker
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mediso Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. MILabs B.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. MR Solutions
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. TriFoil Imaging
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. PerkinElmer Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Fujifilm VisualSonics Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Cubresa Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients